Analysts at Citigroup downgrade Brightpoint Inc CELL from “buy” to “hold.” The target price for CELL has been lowered from $17.50 to $11.
CELL shares fell 2.99% to close at $10.38 yesterday.
More Analyst Ratings here
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: DowngradesPrice TargetAnalyst RatingsCitigroupInformation TechnologyTechnology Distributors
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in
